Table I.
Information of all studies with miR-132-3p expression data.
| Patients | Control | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Study | Year | Country | Platform | n | Mean | SD | n | Mean | SD | t | P-value | (Refs.) |
| GSE85589 | 2016 | South Korea | GPL19117 | 101 | 0.7245 | 0.29268 | 19 | 0.7639 | 0.22898 | 0.555 | 0.58 | – |
| GSE60978 | 2015 | Norway | GPL15159 | 8 | 8.1602 | 0.36503 | 6 | 7.3325 | 1.2594 | −1.783 | 0.1 | (68) |
| GSE59856 | 2015 | Japan | GPL18941 | 98 | 2.6523 | 0.22236 | 150 | 2.6411 | 0.17843 | −0.436 | 0.663 | (69) |
| GSE57555 | 2015 | Japan | GPL18044 | 11 | −0.0022 | 0.07204 | 11 | −0.0143 | 0.07242 | −0.393 | 0.698 | (70) |
| GSE53992 | 2014 | USA | GPL18159 | 16 | −3.6742 | 0.8184 | 28 | −5.214 | 2.1984 | −2.686 | 0.01 | (71) |
| GSE53870 | 2015 | China | GPL18118 | 63 | 9.2162 | 0.20197 | 9 | 10.2856 | 0.93524 | 3.419 | 0.009 | – |
| GSE47764 | 2013 | China | GPL11487 | 3 | 5.9577 | 0.27337 | 3 | 4.7176 | 0.13126 | −7.083 | 0.002 | (72) |
| GSE32957 | 2012 | USA | GPL14732 | 23 | 5.7495 | 0.90686 | 5 | 3.9843 | 0.7151 | −4.065 | <0.001 | (73) |
| TCGA | – | – | – | 36 | 6.9586 | 0.52035 | 9 | 6.3613 | 0.51683 | −3.084 | 0.004 | – |
| RT-qPCR | 2019 | China | – | 25 | 2.4634 | 1.59019 | 22 | 1.0190 | 0.83004 | −3.969 | <0.001 | – |
RT-qPCR, reverse transcription-quantitative PCR; TCGA, The Cancer Genome Atlas.